Find uplifting stories about heroes, innovations, and solutions
9630 results for "metastatic cancer treatment"
A groundbreaking combination therapy is giving women with HER2-positive metastatic breast cancer significantly more time, setting a new standard for first-line treatment. The DESTINY-Breast09 trial shows the treatment works across different patient groups, offering hope to thousands.
Blood cancer patients in Kansas can now access a one-time therapy that could replace lifelong chemotherapy cycles. The breakthrough CAR T-cell treatment genetically modifies patients' own immune cells to fight cancer.
Women with an aggressive form of breast cancer now have two powerful new treatment options that work better than chemotherapy alone. The drugs represent the first major breakthrough in over 20 years for treating metastatic triple-negative breast cancer.
Doctors are catching ovarian cancer earlier and keeping it away longer with personalized treatments and genetic testing. These advances are giving patients real hope where there was once only uncertainty.
Scientists discovered how to beat triple-negative breast cancer at its own game by blocking an enzyme that helps tumors survive treatment. The approach not only damages cancer cells directly but also calls in the immune system for backup.
A groundbreaking study will use advanced imaging to personalize cancer treatment, potentially cutting unnecessary therapy while helping more patients access care. The collaboration could transform how doctors decide when prostate cancer patients have received enough treatment.
Men with early-stage metastatic prostate cancer can now postpone harsh hormone therapy for nearly two years thanks to a breakthrough radiation treatment. The therapy works from inside the body and causes few side effects while preserving quality of life.
Women with triple-negative breast cancer just gained two powerful new treatment options that work better than standard chemotherapy at keeping the disease under control. The FDA approved Trodelvy alone and combined with immunotherapy as first-line treatments for this aggressive cancer type.
Scientists at UCLA discovered how to make targeted cancer drugs more effective against deadly prostate cancer by combining them with a protein blocker. The breakthrough could help patients whose cancer stopped responding to standard treatments.
A groundbreaking cancer treatment just gave patients with hard-to-treat lung cancer something they desperately needed: hope. Chinese biotech company Akeso's new drug ivonescimab beat the current standard treatment in a major clinical trial, marking a historic win for patients with limited options.
The FDA just approved five new breast cancer treatments that give patients more hope than ever before, especially those facing the hardest-to-treat forms. Women who previously had few options now have powerful new weapons in their fight.
Scientists in Japan discovered that an immune protein older than blood itself could help cancer treatments work better when it's produced directly inside tumors. The breakthrough has already extended survival in mice with treatment-resistant cancer.
Scientists created a peptide that acts like a GPS tracker for metastatic breast cancer cells, successfully targeting and destroying them in mice without harming healthy tissue. The discovery could transform treatment for aggressive cancers that have spread beyond their original location.
A small Canadian city is funding a massive expansion that will bring lifesaving chemotherapy care closer to home for cancer patients who currently face exhausting travel for treatment. Breast cancer survivor Teri Peters knows firsthand why six new treatment chairs will change everything.
Men with spreading prostate cancer can now postpone harsh hormone therapy for over two years thanks to a targeted radiation treatment that leaves healthy tissue untouched. A quarter of patients showed no tumors after treatment.
A short burst of immunotherapy before surgery has kept every patient in a UK colorectal cancer trial cancer-free for nearly three years. The breakthrough challenges decades of standard treatment and offers hope for thousands.
Scientists at Oregon Health & Science University discovered that stress nerves help pancreatic tumors grow, opening doors to potential new treatments. The breakthrough could transform how we fight one of the deadliest cancers.
A new radiation treatment for advanced prostate cancer is helping patients skip harsh chemotherapy while getting better results. Texas Oncology in Longview is now offering Pluvicto, which delivers radiation directly to cancer cells.
A new targeted therapy for a rare form of lung cancer just earned priority review from the FDA, potentially offering hope to thousands of patients who currently have limited treatment options. The drug specifically targets HER2 mutations found in about 2-4% of lung cancer cases.
The FDA just approved Optune Pax, a new treatment option for people battling locally advanced pancreatic cancer. This approval brings fresh hope to patients facing one of the most challenging cancer diagnoses.
Showing 20 of 9630